Healthcare - Biotechnology - NASDAQ - US
$ 9.63
-13.6 %
$ 477 M
Market Cap
-1.92
P/E
Price Target
Average
245.28%
Revenue Forecast
Estimate
55.09%
EBIT
Estimate
--6.80%
Net Income
Estimate
47.87%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
REGENXBIO Inc.
Wall Street analysts predict an average 1-year price target for RGNX of $33.2 , with forecasts ranging from a low of $18 to a high of $40 .
RGNX Lowest Price Target
Wall Street Target
18 USD
86.92%
RGNX Average Price Target
Wall Street Target
33.2 USD
245.28%
RGNX Highest Price Target
Wall Street Target
40 USD
315.37%
REVENUE FORECAST
Revenue Forecast Chart RGNX
EBIT FORECAST
EBIT Forecast Chart RGNX
NET INCOME FORECAST
Net Income Chart RGNX